My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.280 -0.010 (-0.44%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings ↗

May 15, 2024

GoodRX shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroger Co. (NYSE:KR).

Via Benzinga

NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday ↗

May 15, 2024

Via Benzinga

GoodRx (GDRX) Q1 2024 Earnings Call Transcript ↗

May 09, 2024

GDRX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024 ↗

May 09, 2024

GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook.

Via Benzinga

GDRX Stock Earnings: GoodRx Holdings Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

GDRX stock results show that GoodRx Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Why GoodRx Surged Today ↗

March 25, 2024

The prescription-drug upstart got an upgrade from Wall Street.

Via The Motley Fool

The Latest Analyst Ratings For GoodRx Holdings ↗

March 25, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings ↗

April 10, 2024

GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.

Via Benzinga

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says ↗

March 25, 2024

Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.

Via Benzinga

In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings ↗

February 26, 2024

Via Benzinga

Unveiling 7 Analyst Insights On GoodRx Holdings ↗

January 02, 2024

Via Benzinga

Where GoodRx Holdings Stands With Analysts ↗

November 10, 2023

Via Benzinga

Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 25, 2024

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.

Via Benzinga

Topics Stocks

These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings ↗

March 01, 2024

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates.

Via Benzinga

Why GoodRx Stock Soared Today ↗

February 29, 2024

The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.

Via The Motley Fool

GoodRx (GDRX) Q4 2023 Earnings Call Transcript ↗

February 29, 2024

GDRX earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Why Is Telemedicine Firm GoodRx's Shares Surging Today ↗

February 29, 2024

GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program.

Via Benzinga

Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars ↗

January 10, 2024

GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.

Via Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Election Edge: 7 Stocks to Snag Before the 2024 Presidential Race Heats Up ↗

January 09, 2024

Election stocks include companies at the center of national conversation and those likely to get increased government funding.

Via InvestorPlace

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 02, 2024

Shares of Longboard Pharmaceuticals, Inc.

Via Benzinga

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

This Analyst With 84% Accuracy Rate Sees Around 22% Upside In NVIDIA - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

November 20, 2023

U.S. stocks closed slightly higher on Friday, with the S&P 500 notching gains for the third straight week. The S&P 500 gained 2.2% last week, while the Dow Jones ended the week with a 1.9% gain.

Via Benzinga

Topics Stocks

HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 13, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Via Benzinga

Why GoodRx Holdings Stock Dived by Nearly 19% Today ↗

November 09, 2023

An unimpressive quarter featuring weak guidance led investors to hit the sell button.

Via The Motley Fool

Why Is Telemedicine Firm GoodRx's Stock Trading Lower Today? ↗

November 09, 2023

GoodRx Holdings Inc's (NASDAQ: GDRX) Q3 sales decreased 4% Y/Y to $180.0 million compared to $187.3 million, primarily due to a $10.0 million contract termination payment to a client, partially offset...

Via Benzinga

GoodRx (GDRX) Q3 2023 Earnings Call Transcript ↗

November 09, 2023

GDRX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.